ezogabine has been researched along with Drug Refractory Epilepsy in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gautier, NM; Glasscock, E; Mishra, V; Vanhoof-Villalba, SL | 1 |
| Brodie, MJ | 1 |
| Elger, CE; Graf, W; Hamer, HM; Kasper, B; Kull, A; Kurth, C; Nass, RD; Rosenow, F; Steinhoff, BJ; Strzelczyk, A; Surges, R | 1 |
| Kwan, P; Lim, KS; Lotay, N; White, R | 1 |
1 review(s) available for ezogabine and Drug Refractory Epilepsy
| Article | Year |
|---|---|
Practical Use of Newer Antiepileptic Drugs as Adjunctive Therapy in Focal Epilepsy.
Topics: Acetamides; Adult; Aged; Animals; Anticonvulsants; Carbamates; Dibenzazepines; Drug Resistant Epilepsy; Epilepsies, Partial; Female; Humans; Lacosamide; Male; Middle Aged; Nitriles; Phenylenediamines; Pyridones | 2015 |
1 trial(s) available for ezogabine and Drug Refractory Epilepsy
| Article | Year |
|---|---|
Efficacy and safety of retigabine/ezogabine as adjunctive therapy in adult Asian patients with drug-resistant partial-onset seizures: A randomized, placebo-controlled Phase III study.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamates; Double-Blind Method; Drug Resistant Epilepsy; Epilepsies, Partial; Female; Humans; Male; Middle Aged; Phenylenediamines; Seizures; Skin Pigmentation; Treatment Outcome; Young Adult | 2016 |
2 other study(ies) available for ezogabine and Drug Refractory Epilepsy
| Article | Year |
|---|---|
Pharmacogenetics of KCNQ channel activation in 2 potassium channelopathy mouse models of epilepsy.
Topics: Animals; Anticonvulsants; Atrioventricular Block; Behavior, Animal; Bradycardia; Carbamates; Channelopathies; Death, Sudden; Disease Models, Animal; Drug Resistance; Drug Resistant Epilepsy; Electroencephalography; Epilepsy; Gene Expression Profiling; Heart Rate; KCNQ Potassium Channels; KCNQ1 Potassium Channel; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Kv1.1 Potassium Channel; Mice; Nerve Tissue Proteins; Pharmacogenetics; Pharmacogenomic Testing; Phenylenediamines; RNA, Messenger; Transcriptome | 2018 |
Adjunctive retigabine in refractory focal epilepsy: Postmarketing experience at four tertiary epilepsy care centers in Germany.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamates; Child; Death, Sudden, Cardiac; Drug Resistant Epilepsy; Electrocardiography; Epilepsies, Partial; Female; Germany; Humans; Incidence; Male; Middle Aged; Phenylenediamines; Product Surveillance, Postmarketing; Retrospective Studies; Seizures; Tertiary Care Centers; Treatment Outcome; Young Adult | 2016 |